| Comfort Healthcare Therapy Llc | |
|
714 W 53rd St, Suite A, Anderson, IN 46013-1514 | |
| (765) 683-0633 | |
| (765) 683-0603 |
| Full Name | Comfort Healthcare Therapy Llc |
|---|---|
| Type | Facility |
| Speciality | Rehabilitation Practitioner |
| Location | 714 W 53rd St, Anderson, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831335231 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Comfort Healthcare Therapy Llc 714 W 53rd St, Suite A, Anderson, IN 46013-1514 Ph: (317) 748-4032 | Comfort Healthcare Therapy Llc 714 W 53rd St, Suite A, Anderson, IN 46013-1514 Ph: (765) 683-0633 |
News Archive
Researchers at the Georgia Institute of Technology, collaborating with pediatric cardiologists and surgeons at The Children's Hospital of Philadelphia, have developed a tool for virtual surgery that allows heart surgeons to view the predicted effects of different surgical approaches. By manipulating three-dimensional cardiac magnetic resonance images of a patient's specific anatomy, physicians can compare how alternative approaches affect blood flow and expected outcomes, and can select the best approach for each patient before entering the operating room.
Cancer therapies are designed to kill tumor cells, but produce tumor cell debris in the process. In a study published in The Journal of Experimental Medicine, researchers from Brigham and Women's Hospital and colleagues show that leftover debris can stimulate inflammation and tumor growth, but that molecules called resolvins can block that unwanted inflammatory response.
​Sleep disturbance is an extremely common complaint following orthopaedic trauma. In a new study presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), researchers assessed the functional status of 1,095 patients following acute fractures to the proximal humerus (shoulder), distal radius (wrist), ankle and tibial plateau (shinbone), using standard orthopaedic tests and assessments.
Precision Antibody(TM) has been selected as the antibody developer for a component of the National Cancer Institute (NCI)'s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.
The National Comprehensive Cancer Network and the NCCN Foundation today announced six new recipients for the 2021 NCCN Foundation Young Investigator Awards Program.
› Verified 8 days ago